A phase I trial of suppository form of BKR-013 in subjects with type 2 diabetes patients.
Phase of Trial: Phase I
Latest Information Update: 26 May 2016
At a glance
- Drugs Glutamine (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 26 May 2016 New trial record
- 27 Aug 2014 According to a BioKier media release, results from this trial expected by the year end 2014.